BR0316991A - Compostos de anel de 1,3-diidro-imidazol fundido - Google Patents
Compostos de anel de 1,3-diidro-imidazol fundidoInfo
- Publication number
- BR0316991A BR0316991A BR0316991-0A BR0316991A BR0316991A BR 0316991 A BR0316991 A BR 0316991A BR 0316991 A BR0316991 A BR 0316991A BR 0316991 A BR0316991 A BR 0316991A
- Authority
- BR
- Brazil
- Prior art keywords
- formula
- denotes
- substituents
- fused
- ring compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
Abstract
"COMPOSTOS DE ANEL DE 1,3-DIIDRO-IMIDAZOL FUNDIDO". A presente invenção refere-se a compostos que mostram excelente atividade de inibição de DPPIV. A presente invenção fornece compostos representados pela fórmula geral (I), sais destes, ou hidratos destes, ¢na qual, T¬ 1¬ significa um heterociclo de 4 a 12 membros monocíclico ou bicíclico tendo 1 ou 2 átomos de nitrogênio no anel, que pode ter substituintes; na fórmula (I), a seguinte fórmula representa uma ligação dupla ou uma única ligação; X¬ 3¬ denota um átomo de oxigênio ou um átomo de enxofre; X¬ 1¬ denota um grupo de C~ 2-6, alquinila que pode ter substituintes; Z¬ 1¬ denota um átomo de nitrogênio ou a fórmula -CR¬ 3¬=; Z¬ 2¬ e Z¬ 3¬ cada qual independentemente denotam um átomo de nitrogênio, a fórmula -CR¬ 1¬=, um grupo de carbonila, ou a fórmula -NR¬ 2¬-; R¬ 1¬, R¬ 2¬, R¬ 3¬, eX¬ 2¬ cada qual independentemente denota um grupo de C~ 1-6~ alquila que pode ter substituintes, e similares.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002352186 | 2002-12-04 | ||
PCT/JP2003/015402 WO2004050656A1 (ja) | 2002-12-04 | 2003-12-02 | 1,3−ジヒドロ−イミダゾール縮合環化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0316991A true BR0316991A (pt) | 2005-10-25 |
Family
ID=32463216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0316991-0A BR0316991A (pt) | 2002-12-04 | 2003-12-02 | Compostos de anel de 1,3-diidro-imidazol fundido |
Country Status (17)
Country | Link |
---|---|
US (1) | US7524847B2 (pt) |
EP (1) | EP1568699A4 (pt) |
JP (1) | JP4279784B2 (pt) |
KR (1) | KR100867484B1 (pt) |
CN (1) | CN100376573C (pt) |
AU (1) | AU2003302657B8 (pt) |
BR (1) | BR0316991A (pt) |
CA (1) | CA2507763A1 (pt) |
HK (1) | HK1086556A1 (pt) |
IL (1) | IL168784A (pt) |
MX (1) | MXPA05005983A (pt) |
NO (1) | NO20053246L (pt) |
NZ (1) | NZ540495A (pt) |
PL (1) | PL377187A1 (pt) |
RU (1) | RU2328498C9 (pt) |
WO (1) | WO2004050656A1 (pt) |
ZA (1) | ZA200504973B (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1338595B1 (en) | 2002-02-25 | 2006-05-03 | Eisai Co., Ltd. | Xanthine derivatives as DPP-IV inhibitors |
RU2297418C9 (ru) | 2002-06-06 | 2009-01-27 | Эйсай Ко., Лтд. | Новые конденсированные производные имидазола, ингибитор дипептидилпептидазы iv, фармацевтическая композиция, способ лечения и применение на их основе |
US7687638B2 (en) * | 2004-06-04 | 2010-03-30 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
UY29177A1 (es) | 2004-10-25 | 2006-05-31 | Astex Therapeutics Ltd | Derivados sustituidos de purina, purinona y deazapurina, composiciones que los contienen métodos para su preparación y sus usos |
MY179032A (en) * | 2004-10-25 | 2020-10-26 | Cancer Research Tech Ltd | Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors |
AU2006290205B2 (en) | 2005-09-14 | 2012-12-13 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetes |
WO2007035629A2 (en) | 2005-09-16 | 2007-03-29 | Takeda Pharmaceutical Company Limited | Process for the preparation of pyrimidinedione derivatives |
WO2007112347A1 (en) | 2006-03-28 | 2007-10-04 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
US8796293B2 (en) * | 2006-04-25 | 2014-08-05 | Astex Therapeutics Limited | Purine and deazapurine derivatives as pharmaceutical compounds |
WO2007125320A1 (en) * | 2006-04-25 | 2007-11-08 | Astex Therapeutics Limited | Pharmaceutical compounds |
TW200838536A (en) | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
WO2009047563A1 (en) | 2007-10-11 | 2009-04-16 | Astrazeneca Ab | Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors |
JP5630867B2 (ja) * | 2008-08-05 | 2014-11-26 | 第一三共株式会社 | イミダゾピリジン−2−オン誘導体 |
US8901132B2 (en) * | 2009-03-13 | 2014-12-02 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Thiazolopyrimidine modulators as immunosuppressive agents |
CN102127070A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
CN102153538B (zh) * | 2010-02-11 | 2013-12-11 | 山东轩竹医药科技有限公司 | 苯并环衍生物 |
CN102276627B (zh) * | 2010-04-29 | 2013-07-31 | 山东轩竹医药科技有限公司 | 吡啶并杂环衍生物 |
CN102234281B (zh) * | 2010-04-29 | 2013-03-27 | 山东轩竹医药科技有限公司 | 嘧啶并环衍生物 |
PL2694056T3 (pl) | 2011-04-01 | 2020-03-31 | Astrazeneca Ab | Leczenie terapeutyczne |
EP2730575B1 (en) * | 2011-07-09 | 2015-09-16 | Xuanzhu Pharma Co., Ltd. | Crystal form i of salt of dipeptidyl peptidase-iv inhibitor and preparation method and use thereof |
MY175800A (en) | 2011-11-30 | 2020-07-09 | Astrazeneca Ab | Combination treatment of cancer |
US8501724B1 (en) * | 2012-01-31 | 2013-08-06 | Pharmacyclics, Inc. | Purinone compounds as kinase inhibitors |
AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
WO2015078799A1 (en) * | 2013-11-27 | 2015-06-04 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
CN110872297B (zh) * | 2018-09-04 | 2023-02-14 | 上海再极医药科技有限公司 | 氨基嘧啶并五元杂环化合物、其中间体、制备方法、药物组合物及应用 |
CN109608462B (zh) * | 2018-12-15 | 2021-11-23 | 华南理工大学 | 一种7-烃基-9-烷氧/硫基嘌呤-8-酮类化合物及其合成方法与在药物中的应用 |
US11691963B2 (en) | 2020-05-06 | 2023-07-04 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
EP4267574A1 (en) | 2020-12-23 | 2023-11-01 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors |
US11970494B2 (en) | 2021-11-09 | 2024-04-30 | Ajax Therapeutics, Inc. | 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL87149A (en) * | 1987-07-20 | 1994-05-30 | Merck & Co Inc | 6-Piperazinyl derivatives of purine and its 3- and 9-deaza isosteres, their preparation and pharmaceutical compositions containing them |
US5057517A (en) * | 1987-07-20 | 1991-10-15 | Merck & Co., Inc. | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
JP2000086663A (ja) | 1998-09-09 | 2000-03-28 | Taisho Pharmaceut Co Ltd | アリールテトラヒドロピリジン誘導体 |
AU756702B2 (en) | 1999-03-11 | 2003-01-23 | Taisho Pharmaceutical Co., Ltd. | Carbamoyl tetrahydropyridine derivatives |
JP2001151777A (ja) | 1999-03-11 | 2001-06-05 | Taisho Pharmaceut Co Ltd | カルバモイルテトラヒドロピリジン誘導体 |
EP1338595B1 (en) | 2002-02-25 | 2006-05-03 | Eisai Co., Ltd. | Xanthine derivatives as DPP-IV inhibitors |
RU2297418C9 (ru) * | 2002-06-06 | 2009-01-27 | Эйсай Ко., Лтд. | Новые конденсированные производные имидазола, ингибитор дипептидилпептидазы iv, фармацевтическая композиция, способ лечения и применение на их основе |
MXPA05003252A (es) | 2002-09-26 | 2005-07-05 | Eisai Co Ltd | Farmaco de combinacion. |
AU2003284142A1 (en) * | 2002-10-15 | 2004-05-04 | Synta Pharmaceuticals Corp | Aromatic bicyclic heterocyles to modulate 1L-12 production |
JP4842829B2 (ja) | 2003-10-31 | 2011-12-21 | 武田薬品工業株式会社 | 含窒素縮合複素環化合物 |
CA2554809C (en) * | 2004-02-05 | 2014-04-29 | Probiodrug Ag | Novel n-alkyl thiourea- and thioamide-substituted imidazolyl inhibitors of glutaminyl cyclase |
-
2003
- 2003-12-02 AU AU2003302657A patent/AU2003302657B8/en not_active Ceased
- 2003-12-02 JP JP2004556886A patent/JP4279784B2/ja not_active Expired - Fee Related
- 2003-12-02 BR BR0316991-0A patent/BR0316991A/pt not_active IP Right Cessation
- 2003-12-02 NZ NZ540495A patent/NZ540495A/en not_active IP Right Cessation
- 2003-12-02 MX MXPA05005983A patent/MXPA05005983A/es unknown
- 2003-12-02 EP EP03812368A patent/EP1568699A4/en not_active Withdrawn
- 2003-12-02 CA CA002507763A patent/CA2507763A1/en not_active Abandoned
- 2003-12-02 CN CNB2003801095193A patent/CN100376573C/zh not_active Expired - Fee Related
- 2003-12-02 US US10/537,227 patent/US7524847B2/en not_active Expired - Fee Related
- 2003-12-02 PL PL377187A patent/PL377187A1/pl not_active Application Discontinuation
- 2003-12-02 KR KR1020057010179A patent/KR100867484B1/ko not_active IP Right Cessation
- 2003-12-02 WO PCT/JP2003/015402 patent/WO2004050656A1/ja active Application Filing
- 2003-12-02 RU RU2005120780/04A patent/RU2328498C9/ru not_active IP Right Cessation
-
2005
- 2005-05-25 IL IL168784A patent/IL168784A/en not_active IP Right Cessation
- 2005-06-20 ZA ZA200504973A patent/ZA200504973B/en unknown
- 2005-07-01 NO NO20053246A patent/NO20053246L/no not_active Application Discontinuation
-
2006
- 2006-06-07 HK HK06106475A patent/HK1086556A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1568699A1 (en) | 2005-08-31 |
US7524847B2 (en) | 2009-04-28 |
MXPA05005983A (es) | 2005-08-18 |
AU2003302657B2 (en) | 2009-09-24 |
HK1086556A1 (en) | 2006-09-22 |
RU2005120780A (ru) | 2006-01-20 |
ZA200504973B (en) | 2006-04-26 |
AU2003302657A2 (en) | 2004-06-23 |
NO20053246D0 (no) | 2005-07-01 |
CN100376573C (zh) | 2008-03-26 |
AU2003302657A1 (en) | 2004-06-23 |
CN1745080A (zh) | 2006-03-08 |
CA2507763A1 (en) | 2004-06-17 |
KR20050087825A (ko) | 2005-08-31 |
JP4279784B2 (ja) | 2009-06-17 |
IL168784A (en) | 2010-12-30 |
JPWO2004050656A1 (ja) | 2006-03-30 |
KR100867484B1 (ko) | 2008-11-06 |
RU2328498C2 (ru) | 2008-07-10 |
AU2003302657B8 (en) | 2009-12-03 |
RU2328498C9 (ru) | 2008-12-10 |
EP1568699A4 (en) | 2007-08-15 |
NZ540495A (en) | 2007-09-28 |
NO20053246L (no) | 2005-08-30 |
PL377187A1 (pl) | 2006-01-23 |
US20060111362A1 (en) | 2006-05-25 |
WO2004050656A1 (ja) | 2004-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0316991A (pt) | Compostos de anel de 1,3-diidro-imidazol fundido | |
BR0311697A (pt) | Novos derivados condensados de imidazol | |
BRPI0506817A (pt) | inibidores seletivos de quinase | |
MX9206114A (es) | Derivados de urea y proceso para su preparacion | |
BR0114436A (pt) | Composto com anel de cinco elementos contendo nitrogênio alifático | |
BRPI0413991A (pt) | composto ativador de ppar e composição farmacêutica contendo o mesmo | |
BRPI0509258A (pt) | composto de 8-oxoadenina 9-substituìda | |
BRPI0514644A (pt) | composto fosforamidita, composto ácido ribonucléico, e método para produzir oligo-rna | |
BR0308261A (pt) | Métodos extrativos para puruficação de sucralose | |
BR9911048A (pt) | Inibidor de spla2 de pirrolo[1,2-b]piridazina | |
BRPI0606480A (pt) | compostos farmacêuticos | |
EA200870321A1 (ru) | Способ получения 4-оксохинолинового соединения | |
BR0206670A (pt) | Compostos halogenados que exibem agonismo para receptor de trombopoietina | |
BR0108303A (pt) | Derivados do 1h-imidazopiridina | |
BRPI0518068A (pt) | composto ou um éster ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, inibidor seletivo de aurora a, agente anti-tumor, e, preparação combinada | |
BRPI0818193B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
BR0309522A (pt) | Compostos piridina ou sais destes e herbicidas contendo os mesmos | |
ATE273305T1 (de) | Thrombin-inhibitoren | |
DOP2006000060A (es) | Compuestos de n-sulfonilaminofeniletil -2-fenoxiacetamida sustituida | |
TW200612920A (en) | Novel imidazolidine derivatives | |
DK1436257T3 (da) | Oxim-analogica af 1-alpha, 25-dihydroxy-vitamin-D3 med ringe kalcemisk virkning | |
DK0888271T3 (da) | Benzamidinderivater substitueret med aminosyre- og hydroxysyrederivater og deres anvendelse som antikoagulerende midler | |
BRPI0509095A (pt) | método para produzir um composto aminofenol | |
TW200710173A (en) | Nitrosulfide dyes | |
BR0311410A (pt) | Composto de piperidina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: EISAI RANDD MANAGEMENT CO., LTD. (JP) Free format text: TRANSFERIDO DE: EISAI CO., LTD. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |